Improved production of Humira antibody in the genetically engineered Escherichia coli SHuffle, by co-expression of human PDI-GPx7 fusions
UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
Vitamin B12 contributes to: normal energy metabolism
Rousseau G, Signolet I, Denis MC, Chao de la Barca JM, Mahieu R, Letournel F, Reynier P, Simard G
Optical biosensor consisting of glutathione-S-transferase for detection of captan
Based on this redox framework, we investigated whether nitrosative chemistry could facilitate disulfide-mediated TTR conversion by using S-nitrosoglutathione (GSNO) as a physiological S-nitrosylating agent